Gamma interferon (IFN-g) is a regulator of cell growth, which suppresses the proliferation of HT-29 colon carcinoma cells. Here we show that in HT-29 cells IFN-g transiently increased the cellular level of the tyrosine kinase Fer, whose functioning was found to be essential for the proliferation of malignant cell-lines. The transient elevation in the level of Fer, was followed by its down-regulation, an effect which was most prominent after 6 -8 h of IFN-g treatment. Up-and downregulation of Fer was paralleled by the activation and subsequent deactivation of Stat3, which is a potent oncogene and a putative substrate of the tyrosine kinase Fer. Moreover, IFN-g induced the association of Fer and Stat3 and the newly formed complex was most stable at the down-regulated states of the two proteins. Formation of the Fer/Stat3 complex was accompanied by an attenuation in cell -cycle progression and accumulation of cells in the G1 phase. Thus, Fer and Stat3 are two proliferation-promoting factors whose down-regulation could contribute to the cytostatic activity of IFN-g in colon carcinoma cells.
Interferons (IFNs) are cytokines that play a complex and central role in the resistance of mammalian hosts to pathogens. Immune-type II, also termed g-interferon (IFN-g), is secreted by activated T-cells and by natural killer (NK) cells (Sen and Lengyel, 1992) . IFN-g modulates a number of immune functions such as the expression of major histocompatibility complex (MHC) antigens and Fc receptors (Trinchieri and Perussia, 1984) , macrophage activation (Nacy and Meltzer, 1991) and B-cell functions (Finkleman et al., 1990) .
Binding of IFN-g to its heterodimeric receptor induces activation of the Janus kinases: JAK1 and JAK2 (Darnell et al., 1994; Rane and Reddy, 2000) . This activation is followed by phosphorylation of STAT (signal transducers and activators of transcription) proteins Shuai et al., 1992 Shuai et al., , 1993 . Whereas tyrosine phosphorylation of Stat1 occurs in all cells (Shuai et al., 1993) , activation of Stat3 (Caldenhoven et al., 1999) and Stat4 (Woldman et al., 2001) by IFN-g, is cell-type restricted. The phosphorylated STAT proteins translocate to the nucleus, wherein they bind to specific regulatory DNA sequences, and activate the transcription of defined genes (Bromberg and Chen, 2001) .
Interferons are also known to possess potent antitumor activities. For example, IFN-g and IFN-a were shown to inhibit the proliferation of PC3 and DU145 prostate cancer cell lines (van Moorselaar et al., 1991) . In addition, previous studies have indicated that IFNs are capable of modulating the expression of various suppressor genes and oncogenes (Hobeika et al., 1998; Kominsky et al., 2000) .
Fer is an evolutionary conserved (Paulson et al., 1997; Pawson et al., 1989) nonreceptor tyrosine kinase encoded by the FER locus in human , mouse (Fischman et al., 1990) , rat (Letwin et al., 1988) , and Drosophila (Paulson et al., 1997) . The expression of Fer is widespread, and it is found in most mammalian cells Letwin et al., 1988) . However, it was not detected in pre-B, pre-T, and T-cells in the mouse . Fer carries a 412 aa long N-terminal tail with three coiled-coil (CC)-forming domains (Ben-Dor et al., 1999; Kim and Wong, 1995) which have been implicated in directing the subcellular localization (Letwin et al., 1988) and oligomerization (Craig et al., 1999; Orlovsky et al., 2000) of this kinase.
In the cytoplasm, Fer associates with cell -cell adhesion molecules (Kim and Wong, 1995; Rosato et al., 1998) and its activity is induced in cells stimulated by growth factors (Kim and Wong, 1995) . Thus, Fer is most probably involved in growth-promoting pathways, a notion which is supported by the ability of Fer to activate the proliferation promoting factor, Stat3 . Moreover, while the function of Fer is redundant in normal cells (Craig et al., 2001 ) the expression of Fer was found to be essential for the proliferation of malignant cell-lines (Allard et al., 2000; Orlovsky et al., 2000) . Fer was also shown to associate with the FceRI receptor in mast cells (Penhallow et al., 1995) , with signaling complexes containing the insulin receptor substrate-1 (IRS1) and with an activated phosphatidylinositol 3-kinase in adipocytes (Iwanishi et al., 2000) .
To further explore the role of Fer in the proliferation of malignant cells, we analysed the effects of agents that suppress malignant growth on the Fer-kinase activity using the growth inhibition of the colon cancer cell line HT-29 by IFN-g as a model system (Chen et al., 2000) .
Actively growing, subconfluent HT-29 cells were stimulated with 20 ng/ml IFN-g for time periods ranging from 1 to 24 h. Whole cell protein extracts from untreated and IFN-g treated cells, were resolved in SDS -PAGE, after which they were reacted with anti-FER (Orlovsky et al., 2000; Priel-Halachmi et al., 2000) and anti-actin antibodies in a Western blot analysis. While the levels of actin were not affected by the IFN-g treatment, the levels of Fer fluctuated in the stimulated cells (Figure 1a ,b). Short treatments, ranging from 1 to 4 h, led to a transient increase in the levels of Fer ( Figure 1a , lanes 2 -4). This increase was followed by a decline in the expression of the kinase, which was most prominent after 6 and 8 h of IFN-g treatment. However, the reduction in the expression of Fer was also seen following 24 h of IFN-g-treatment ( Figure 1a lanes 5 -7) . Importantly, a similar profile of Fer expression was obtained when the levels of Fer were determined in whole-cell, tyrosinephosphorylated proteins which were immunoprecipitated using anti-phosphototyrosine (aPT), antibodies ( Figure 1c ). These observations support the notion that IFN-g modulates the cellular levels of Fer.
The effects of IFN-g were concentration-dependent with a maximal effect seen at the IFN-g concentration of 20 ng/ml (data not shown).
One of the putative substrates of Fer is the transcription factor Stat3 which is constitutively activated in various cancer cells (Bowman et al., 2000; Bromberg et al., 1999) . Therefore, we investigated whether the effects of IFN-g on the cellular levels of Fer are reflected in the activation states of Stat3 in HT-29 cells. While the cellular levels of Stat3 were not affected by the IFN-g treatment (Figure 2a) , the tyrosine phosphorylation of Stat3, which reflects the activation state of this factor (Bowman et al., 2000) , increased concurrently with the transient elevation in the levels of Fer (Figure 2b, lanes 2, 3) . Tyrosinephosphorylation of Stat3 was maximal after 4 h of stimulation by IFN-g (Figure 2b , lane 3), but decreased -7) . Whole cells protein extracts were prepared as described (Orlovsky et al., 2000) , resolved in 8% SDS -PAGE, and were then reacted with (a) aFer antibodies in a Western-blot analysis (Orlovsky et al., 2000; Priel-Halachmi et al., 2000) . (b) The same blot as in a was stripped and re-probed with a-actin (Sigma) antibodies. (c) Tyrosine phosphorylated proteins were immunoprecipitated from whole-cell extracts, using aPT antibodies (1 : 250) (4G10-UBI). Precipitates were resolved in a 8% SDS -PAGE and reacted with aFer antibodies in a Western blot analysis. Migration distances of known molecular weight makers are shown on the left. Arrows on the right indicate migration distances of Fer and actin. Migration distances of the precipitating antibodies are also shown in (c). IB, immunoblotting; IP, immunoprecipitation Stimulation of HT-29 cells with IFN-g also led to the activation of Stat1. However, in contrast to Stat3, the tyrosine phosphorylation and activation of Stat1 was stable following treatment with the IFN-g (Figure 2d ). Thus, unlike Stat3, the activation states of Stat1 did not parallel the fluctuations in the cellular levels of Fer. To further study a possible link between changes in Fer expression and the activation states of Stat3, the physical association of Fer and Stat3 was studied in cells that were either treated, or not treated with IFNg. As shown in Figure 3 , immunoprecipitation of Stat3 using anti-Stat3 antibodies led to the co-precipitation of Fer, only after extended IFN-g treatments (6 h and above) (Figure 3b lanes 4 -6) . Appearance of stable Fer/Stat3 complexes paralleled the delayed deactivation of Stat3 after extended treatment of the HT-29 cells with IFN-g ( Figure 3a ,b and Figure 2b) . Moreover, the level of associated Fer could be directly correlated with the dephosphorylation state of Stat3 (Figure 3b , lanes 4 -6), thus implying the preferential association of Fer with in-active Stat3, in IFN-g treated HT-29 cells.
To further substantiate the regulated association of Fer and Stat3 following IFN-g treatment, the coimmunoprecipitation experiments were repeated using the complementary set of antibodies. Fer was immunoprecipitated from whole-cell extracts with anti-FER antibodies, and the precipitated proteins were detected with anti-Stat3 antibodies using a Western blot analysis. Similar to the experiment depicted in Figure  3a ,b, the results demonstrated the association and coimmunoprecipitation of Fer and Stat3 in cells which were subjected to extended IFN-g treatments (6 h and above) (Figure 3d, lanes 4 -6) . This observation supports the conclusion that deactivated Stat3 associates with the tyrosine kinase Fer. However, while the tyrosine phosphorylation levels of Stat3 were similar in untreated cells and in cells treated with IFN-g for 6, 8 and 24 h (Figure 2b lanes 1 and 4 and Figure 3a lanes 1 and 6), the association of Stat3 and Fer was seen only following treatment of cells with IFN-g for at least 6 h (Figure 3b,d) . Thus, the association of Stat3 and Fer does not reflect only a change in the tyrosinephosphorylation state of Stat3, but could also reflect a change imposed by IFN-g, on the activation state of Fer. This would coincide with the observation that autophosphorylated and activated Fer does not associate stably with Stat3 . Thus, stable association of inactive Stat3 with an inactive Fer, could fix or 'lock' the non-functional state of the two proteins.
To further explore a possible link between the biochemical states of Fer and Stat3 and the growth rate of HT-29 cells, IFN-g-treated and untreated cells were subjected to a flow-cytometry analysis. This analysis revealed an increase in the population of the G0/G1 cells, which was maximal after 6 and 8 h of treatment by IFN-g ( Figure 4 and Table 1 ). Moreover, the increase in the G0/G1 fraction of cells, was accompanied by a decline in the percentage of cells in the S phase (Figure 4d -f and Table 1 ). This pattern implies a retardation in the G1 progression. These findings paralleled the decline in the levels of Fer (Figure 1 ) and its association with Stat3 (Figure 3 ), thus suggesting a link between the two cellular events.
Fer was shown to play a pivotal role in the proliferation of various malignant cell lines (Allard et al., 2000) . This suggests that Fer may be a potential Values were obtained from three independent experiments which gave similar results target for modulators of malignant cell-growth. In the current work we showed that Fer could serve as a novel down-stream target of IFN-g, in cells like HT-29 which are sensitive to the cytostatic and cytolytic activities of IFN-g (Chen et al., 2000) . Moreover, the down-regulation of Fer involved its association with inactive Stat3, which upon activation can serve as a potent accelerator of malignant transformation (Bromberg et al., 1999) . Thus the antiproliferative activity of IFN-g on HT-29 cells, may also be mediated through the down-regulation of Fer and Stat3. Further exploration of the molecular mechanisms which underlie the down-regulation of Fer by IFN-g in malignant cells, should extend our understanding of the therapeutic potential of IFN-g, in defined types of cancer.
